SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038054
Filing Date
2023-10-24
Accepted
2023-10-24 09:08:33
Documents
21
Period of Report
2023-10-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41558
2 ex10-2.htm EX-10.2 7671
3 ex10-2_001.jpg GRAPHIC 466124
4 ex10-2_002.jpg GRAPHIC 512820
5 ex10-2_003.jpg GRAPHIC 536025
6 ex10-2_004.jpg GRAPHIC 482050
7 ex10-2_005.jpg GRAPHIC 459609
8 ex10-2_006.jpg GRAPHIC 457857
9 ex10-2_007.jpg GRAPHIC 161687
10 ex10-2_008.jpg GRAPHIC 69772
  Complete submission text file 0001493152-23-038054.txt   4552554

Data Files

Seq Description Document Type Size
11 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrzm-20231018.xsd EX-101.SCH 3015
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrzm-20231018_lab.xml EX-101.LAB 34240
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrzm-20231018_pre.xml EX-101.PRE 22359
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3031
Mailing Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458
Business Address 555 HERITAGE DRIVE SUITE 205 JUPITER FL 33458 561-935-9955
MARIZYME, INC. (Filer) CIK: 0001413754 (see all company filings)

IRS No.: 825464863 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53223 | Film No.: 231341302
SIC: 2834 Pharmaceutical Preparations